##gff-version 3
##sequence-region Q15596 1 1464
Q15596	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19413330;Dbxref=PMID:19413330	
Q15596	UniProtKB	Chain	2	1464	.	.	.	ID=PRO_0000094402;Note=Nuclear receptor coactivator 2	
Q15596	UniProtKB	Domain	26	83	.	.	.	Note=bHLH;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00981	
Q15596	UniProtKB	Domain	119	183	.	.	.	Note=PAS;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00140	
Q15596	UniProtKB	Region	691	743	.	.	.	Note=CASP8AP2-binding;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q15596	UniProtKB	Region	730	1121	.	.	.	Note=Interaction with ARNTL;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q61026	
Q15596	UniProtKB	Motif	641	645	.	.	.	Note=LXXLL motif 1	
Q15596	UniProtKB	Motif	690	694	.	.	.	Note=LXXLL motif 2	
Q15596	UniProtKB	Motif	745	749	.	.	.	Note=LXXLL motif 3	
Q15596	UniProtKB	Motif	878	882	.	.	.	Note=LXXLL motif 4	
Q15596	UniProtKB	Motif	1079	1087	.	.	.	Note=LLXXLXXXL motif	
Q15596	UniProtKB	Compositional bias	1254	1260	.	.	.	Note=Poly-Gln	
Q15596	UniProtKB	Site	869	870	.	.	.	Note=Breakpoint for translocation to form KAT6A-NCOA2;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12676584,ECO:0000269|PubMed:15657427,ECO:0000269|PubMed:9558366;Dbxref=PMID:12676584,PMID:15657427,PMID:9558366	
Q15596	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19413330;Dbxref=PMID:19413330	
Q15596	UniProtKB	Modified residue	29	29	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q15596	UniProtKB	Modified residue	338	338	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q61026	
Q15596	UniProtKB	Modified residue	487	487	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
Q15596	UniProtKB	Modified residue	493	493	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:20068231,PMID:23186163,PMID:24275569	
Q15596	UniProtKB	Modified residue	499	499	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
Q15596	UniProtKB	Modified residue	554	554	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q15596	UniProtKB	Modified residue	565	565	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:23186163,PMID:24275569	
Q15596	UniProtKB	Modified residue	636	636	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q61026	
Q15596	UniProtKB	Modified residue	640	640	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q15596	UniProtKB	Modified residue	682	682	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q15596	UniProtKB	Modified residue	699	699	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:23186163,PMID:24275569	
Q15596	UniProtKB	Modified residue	736	736	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q15596	UniProtKB	Modified residue	771	771	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q15596	UniProtKB	Modified residue	780	780	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q15596	UniProtKB	Modified residue	785	785	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q15596	UniProtKB	Modified residue	864	864	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q61026	
Q15596	UniProtKB	Modified residue	874	874	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q61026	
Q15596	UniProtKB	Modified residue	1173	1173	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q15596	UniProtKB	Modified residue	1177	1177	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q15596	UniProtKB	Modified residue	1190	1190	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q15596	UniProtKB	Modified residue	1196	1196	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q15596	UniProtKB	Modified residue	1203	1203	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q15596	UniProtKB	Modified residue	1221	1221	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q15596	UniProtKB	Modified residue	1240	1240	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q61026	
Q15596	UniProtKB	Modified residue	1261	1261	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q15596	UniProtKB	Modified residue	1266	1266	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q15596	UniProtKB	Cross-link	239	239	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q15596	UniProtKB	Cross-link	648	648	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q15596	UniProtKB	Cross-link	705	705	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q15596	UniProtKB	Cross-link	731	731	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q15596	UniProtKB	Cross-link	785	785	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:28112733	
Q15596	UniProtKB	Cross-link	1454	1454	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q15596	UniProtKB	Natural variant	1282	1282	.	.	.	ID=VAR_024546;Note=M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15489334;Dbxref=dbSNP:rs2228591,PMID:15489334	
Q15596	UniProtKB	Mutagenesis	644	645	.	.	.	Note=By itself%2C does not affect nuclear receptor binding or transcriptional coactivation. Abrogates ligand-induced nuclear receptor binding and transactivation%3B when associated with 693-A-A-694 and 748-A-A-749. LL->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9430642;Dbxref=PMID:9430642	
Q15596	UniProtKB	Mutagenesis	693	694	.	.	.	Note=By itself%2C does not affect nuclear receptor binding or transcriptional coactivation. Abrogates ligand-induced nuclear receptor binding and transactivation%3B when associated with 644-A-A-665 and 748-A-A-749. LL->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9430642;Dbxref=PMID:9430642	
Q15596	UniProtKB	Mutagenesis	748	749	.	.	.	Note=By itself%2C does not affect nuclear receptor binding or transcriptional coactivation. Abrogates ligand-induced nuclear receptor binding and transactivation%3B when associated with 644-A-A-665 and 693-A-A-694. LL->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9430642;Dbxref=PMID:9430642	
Q15596	UniProtKB	Mutagenesis	1079	1083	.	.	.	Note=Reduces transcriptional coactivation and disrupts interaction with CREBBP/CBP. LLDQL->AADQA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9430642;Dbxref=PMID:9430642	
Q15596	UniProtKB	Mutagenesis	1081	1082	.	.	.	Note=Has little effect on transcriptional coactivation. DQ->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9430642;Dbxref=PMID:9430642	
Q15596	UniProtKB	Helix	685	687	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5VB7	
Q15596	UniProtKB	Helix	689	693	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5DXE	
Q15596	UniProtKB	Beta strand	739	741	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1M2Z	
Q15596	UniProtKB	Helix	743	750	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3UP3	
